Kadcyla
Brand Name: Kadcyla
Generic Name: Trastuzumab Emtansine
Active
Registration Number
BR-953
Dosage Form
Powder For Concentrate For Solution For I.V. Infusion
Issuance Date
May 6, 2024
Expiry Date
June 30, 2029
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength100 mg
Packaging15mL Type I Glass Vial sealed with a grey butyl rubber stopper with an aluminum seal and a white plastic flip-off cap (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Monoclonal Antibody
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Trastuzumab EmtansineActive
Monograph: Trastuzumab emtansine